Precision Medicine with TGF-β Inhibition Using Tumor Explants: Comment on “Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor” by N. Sumru Bayin et al.

In a new report, Bayin et al. described an ex vivo explant model to test the patient-specific response to transforming growth factor-β inhibition in high-grade gliomas.

Detalles Bibliográficos
Autores principales: Huang, Haidong, Yu, Jennifer S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156519/
https://www.ncbi.nlm.nih.gov/pubmed/27978995
http://dx.doi.org/10.1016/j.neo.2016.10.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156519/
https://www.ncbi.nlm.nih.gov/pubmed/27978995
http://dx.doi.org/10.1016/j.neo.2016.10.009

Ejemplares similares